Medtronic Settles Patent Suit Against Smiths Medical MD
The settlement allows both companies to sell their existing products without any changes in features or functionality, Medtronic said.
“We were pleased with the court's prior rulings and this settlement, which is positive for Medtronic as well as our patients,” Robert Guezuraga, president of Medtronic Diabetes said in a statement.
In 2003, Medtronic sued Smiths Medical, a St. Paul subsidiary of British medical...
To view the full article, register now.